Related Experiment Video
Updated: Aug 14, 2026
07:56
A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
[Monoamine oxidase, tribulin, isatin: basic and applied medical aspects]
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
|December 1, 1999
Summary
Monoamine oxidase (MAO) inhibitors are crucial for treating neurological disorders. Research into endogenous inhibitors like isatin offers new therapeutic strategies for conditions such as alcoholism and explores their role in natriuretic peptide signaling.
Area of Science:
- Biochemistry
- Neuroscience
- Pharmacology
Context:
- Monoamine oxidase (MAO) degrades neurotransmitters, and its dysregulation is implicated in diseases.
- MAO inhibitors have shown therapeutic potential, necessitating the development of new-generation drugs.
- Endogenous MAO inhibitors, such as tribulin and its component isatin, are present in biological systems.
Purpose:
- To investigate the efficacy of various compounds in inhibiting MAO A and B.
- To explore the biological properties and therapeutic potential of endogenous MAO inhibitors, specifically isatin.
- To examine the role of isatin in natriuretic peptide signaling and its potential as a pharmacological tool.
Summary:
- MAO inhibitors offer therapeutic benefits, and analyzing their efficacy against MAO A and B aids in designing novel inhibitors.
- Tribulin, an endogenous MAO inhibitor fraction, contains isatin, which was investigated for its biological properties.
- Isatin not only inhibits MAO but also affects atrial natriuretic peptide (ANP) receptor binding and ANP-stimulated guanylate cyclase (GC).
Impact:
- Understanding MAO inhibition mechanisms and endogenous regulators like isatin can lead to advanced treatments for neurological disorders.
- Deficiencies in MAO A-inhibiting tribulin components may contribute to alcoholism, suggesting potential therapeutic targets.
- Isatin and its analogues represent valuable pharmacological tools for studying the physiological roles of natriuretic peptides and developing new therapies.
More Related Videos
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
Related Concept Videos
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:29Amino Acid Biosynthetic Pathways
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which provide...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...